# Yan Yu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yan-yu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,590 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 28 |
| i10-index | 60 |
| Last Known Institution | Harbin Medical University |
| OpenAlex ID | https://openalex.org/A5103264433 |
| ORCID iD | 0000-0001-5598-763X |
| Works | 155 |

## Researcher papers

- [Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC](https://scholariq.org/papers/osimertinib-with-or-without-chemotherapy-in-i-egfr-i-mutated-advanced-nsclc/)
- [Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2)](https://scholariq.org/papers/regulation-of-glycolytic-metabolism-by-autophagy-in-liver-cancer-involves/)
- [Acetylation of Beclin 1 inhibits autophagosome maturation and promotes tumour growth](https://scholariq.org/papers/acetylation-of-beclin-1-inhibits-autophagosome-maturation-and-promotes-tumour/)
- [CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression](https://scholariq.org/papers/cul3-cullin-3-mediated-ubiquitination-and-degradation-of-becn1-beclin-1-inhibit/)
- [Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)](https://scholariq.org/papers/toripalimab-plus-chemotherapy-for-patients-with-treatment-naive-advanced-non/)
- [Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation](https://scholariq.org/papers/autophagy-deficiency-promotes-triple-negative-breast-cancer-resistance-to-t-cell/)
- [Fis1 phosphorylation by Met promotes mitochondrial fission and hepatocellular carcinoma metastasis](https://scholariq.org/papers/fis1-phosphorylation-by-met-promotes-mitochondrial-fission-and-hepatocellular/)
- [CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor–Mutated Advanced Non–Small-Cell Lung Cancer](https://scholariq.org/papers/cns-efficacy-of-osimertinib-with-or-without-chemotherapy-in-epidermal-growth/)
- [CaMKII-mediated Beclin 1 phosphorylation regulates autophagy that promotes degradation of Id and neuroblastoma cell differentiation](https://scholariq.org/papers/camkii-mediated-beclin-1-phosphorylation-regulates-autophagy-that-promotes/)
- [Altered microRNA Expression Profiles of Extracellular Vesicles in Nasal Mucus From Patients With Allergic Rhinitis](https://scholariq.org/papers/altered-microrna-expression-profiles-of-extracellular-vesicles-in-nasal-mucus/)
- [685P Genomic profiles in EGFR mutant locally advanced or metastatic NSCLC patients after first-line osimertinib treatment failure: A real-world, multi-center prospective study in China](https://scholariq.org/papers/685p-genomic-profiles-in-egfr-mutant-locally-advanced-or-metastatic-nsclc/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Researcher university

- [Harbin Medical University](https://scholariq.org/institutions/harbin-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.